Clinical trial
A Clinical Trial Exploring the Safety and Efficacy of CT0494BCP CAR-T Cell Injection in Participants With Advanced Gastric/Esophagogastric Junction Adenocarcinoma
NCT07538856 is registered in ClinicalTrials.gov with Beijing GoBroad Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Trial Exploring the Safety and Efficacy of CT0494BCP CAR-T Cell Injection in Participants With Advanced Gastric/Esophagogastric Junction Adenocarcinoma
- Lead sponsor
- Beijing GoBroad Hospital
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- April 30, 2026
- Completion date
- March 31, 2028
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gastric, gastric / gastroesophageal junction adenocarcinoma